Skip to main content
Top
Published in: European Radiology 1/2014

01-01-2014 | Computed Tomography

Evaluation of a method for improving the detection of hepatocellular carcinoma

Authors: Edgar Bendik, Peter B. Noël, Daniela Münzel, Alexander A. Fingerle, Martin Henninger, Christian Markus, Alain Vlassenbroek, Ernst J. Rummeny, Martin Dobritz

Published in: European Radiology | Issue 1/2014

Login to get access

Abstract

Objective

To improve the detection of liver lesions in patients with hepatocellular carcinoma (HCC) via an iodine contrast enhancement tool.

Methods

Thirty-two patients with clinically proven HCCs underwent imaging with a three-phase protocol on a 256-slice MDCT. The contrast enhancement in the reconstructed slices was improved via a post-processing tool. Mean image noise was measured in four different regions: liver lesion, healthy liver, subcutaneous fat and bone. For each image set the image noise and contrast-to-noise ratio (CNR) were assessed. For subjective image assessment, four experienced radiologists evaluated the diagnostic quality.

Results

While employing the post-processing algorithm, CNR between the liver lesion and healthy liver tissue improves significantly by a factor of 1.78 (CNRwithout vC = 2.30 ± 1.92/CNRwith vC = 4.11 ± 3.05) (P* = 0.01). All results could be achieved without a strengthening of artefacts; mean HU values of subcutaneous fat and bone did not significantly change. Subjective image analysis illustrated a significant improvement when employing post-processing for clinically relevant criteria such as diagnostic confidence.

Conclusion

With post-processing we see a significantly improved detection of arterial uptake in hepatic lesions compared with non-processed data. The improvement in CNR was confirmed by subjective image assessment for small lesions and for lesions with limited uptake.

Key Points

• Enhancement with iodine-based contrast agents is an essential part of CT.
• A new post-processing tool significantly improves the diagnostics of hepatocellular carcinoma.
• It also improves detection of small lesions with limited iodine uptake.
Literature
1.
2.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef
3.
go back to reference Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:4–66CrossRef Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:4–66CrossRef
4.
go back to reference Willatt JM, Hussain HK, Adusumilli S, Marrero JA (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311–330PubMedCrossRef Willatt JM, Hussain HK, Adusumilli S, Marrero JA (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311–330PubMedCrossRef
6.
go back to reference Bolog N, Andreisek G, Oancea I, Mangrau A (2011) CT and MR imaging of hepatocellular carcinoma. J Gastrointest Liver Dis 20:181–189 Bolog N, Andreisek G, Oancea I, Mangrau A (2011) CT and MR imaging of hepatocellular carcinoma. J Gastrointest Liver Dis 20:181–189
7.
go back to reference Murakami T, Hori M, Kim T, Kawata S, Abe H, Nakamura H (2004) Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma. Intervirology 47:209–226PubMedCrossRef Murakami T, Hori M, Kim T, Kawata S, Abe H, Nakamura H (2004) Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma. Intervirology 47:209–226PubMedCrossRef
8.
go back to reference Llovet JM, Ducreux M, Lencioni R, Di Bisceglie AM, Galle PR, Dufour JF, Greten TF, Raymond E, Roskams T, De Baere T, Ducreux M, Mazzaferro V, Bernardi M, Bruix J, Colombo M, Zhu A (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943 Llovet JM, Ducreux M, Lencioni R, Di Bisceglie AM, Galle PR, Dufour JF, Greten TF, Raymond E, Roskams T, De Baere T, Ducreux M, Mazzaferro V, Bernardi M, Bruix J, Colombo M, Zhu A (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
9.
go back to reference Bruix J, Sherman M (2005) Practice Guidelines Committee of the AASLD. Management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRef Bruix J, Sherman M (2005) Practice Guidelines Committee of the AASLD. Management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRef
10.
go back to reference Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK (2009) Focal liver lesions: detection and characterisation at double-contrast liver MR imaging with ferocarbotran and gadobutrol versus single-contrast MR imaging. Radiology 253:724–733PubMedCrossRef Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK (2009) Focal liver lesions: detection and characterisation at double-contrast liver MR imaging with ferocarbotran and gadobutrol versus single-contrast MR imaging. Radiology 253:724–733PubMedCrossRef
11.
go back to reference Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, Tsuda K, Osuga K, Kawata S, Nakamura H, Kudo M (2001) Hypervascular hepatocellular carcinoma: detection with double arterial phase multidetector row helical CT. Radiology 218:763–767PubMedCrossRef Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, Tsuda K, Osuga K, Kawata S, Nakamura H, Kudo M (2001) Hypervascular hepatocellular carcinoma: detection with double arterial phase multidetector row helical CT. Radiology 218:763–767PubMedCrossRef
12.
go back to reference Kudo M (1999) Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 19:297–309PubMedCrossRef Kudo M (1999) Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 19:297–309PubMedCrossRef
13.
go back to reference Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F (2005) Characterisation of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedCrossRef Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F (2005) Characterisation of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedCrossRef
14.
go back to reference Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, Hunt LE (2000) Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumour detection rate in 430 cases with surgical pathologic correlation. Radiology 217:743–749PubMedCrossRef Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, Hunt LE (2000) Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumour detection rate in 430 cases with surgical pathologic correlation. Radiology 217:743–749PubMedCrossRef
15.
go back to reference Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ (2005) Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 184:1069–1076PubMedCrossRef Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ (2005) Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 184:1069–1076PubMedCrossRef
16.
go back to reference Ronzoni A, Artioli D, Scardina R, Battistig L, Minola E, Sironi S, Vanzulli A (2007) Role of MDCT in the diagnosis of hepatocellular carcinoma in patients with cirrhosis undergoing orthotopic liver transplantation. AJR Am J Roentgenol 189:792–798PubMedCrossRef Ronzoni A, Artioli D, Scardina R, Battistig L, Minola E, Sironi S, Vanzulli A (2007) Role of MDCT in the diagnosis of hepatocellular carcinoma in patients with cirrhosis undergoing orthotopic liver transplantation. AJR Am J Roentgenol 189:792–798PubMedCrossRef
17.
go back to reference Valls C, Cos M, Figueras J, Andía E, Ramos E, Sánchez A, Serrano T, Torras J (2004) Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol 182:1011–1017PubMedCrossRef Valls C, Cos M, Figueras J, Andía E, Ramos E, Sánchez A, Serrano T, Torras J (2004) Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol 182:1011–1017PubMedCrossRef
18.
go back to reference Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, Joh JW (2000) Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 175:693–698PubMedCrossRef Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, Joh JW (2000) Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 175:693–698PubMedCrossRef
19.
go back to reference Kim YK, Kim CS, Chung GH, Han YM, Lee SY, Chon SB, Lee JM (2006) Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol 186:149–157PubMedCrossRef Kim YK, Kim CS, Chung GH, Han YM, Lee SY, Chon SB, Lee JM (2006) Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol 186:149–157PubMedCrossRef
20.
go back to reference Marin D, Di Martino M, Guerrisi A, De Filippis G, Rossi M, Ginanni Corradini S, Masciangelo R, Catalano C, Passariello R (2009) Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology 251:85–95PubMedCrossRef Marin D, Di Martino M, Guerrisi A, De Filippis G, Rossi M, Ginanni Corradini S, Masciangelo R, Catalano C, Passariello R (2009) Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology 251:85–95PubMedCrossRef
21.
go back to reference Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y, Oi H, Nakamura H (1998) Effects of injection rates of contrast material on arterial phase hepatic CT imaging. AJR Am J Roentgenol 171:429–432PubMedCrossRef Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y, Oi H, Nakamura H (1998) Effects of injection rates of contrast material on arterial phase hepatic CT imaging. AJR Am J Roentgenol 171:429–432PubMedCrossRef
22.
go back to reference Bea KT, Heiken JP, Brink JA (1998) Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate – pharmacokinetic analysis and experimental porcine model. Radiology 206:455–464 Bea KT, Heiken JP, Brink JA (1998) Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate – pharmacokinetic analysis and experimental porcine model. Radiology 206:455–464
23.
go back to reference Awai K, Takeda K, Onishi H, Hori (2002) Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row-helical CT. Radiology 224:757–763PubMedCrossRef Awai K, Takeda K, Onishi H, Hori (2002) Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row-helical CT. Radiology 224:757–763PubMedCrossRef
24.
go back to reference Tanikake M, Shimizu T, Narabayashi I, Matsuki M, Masuda K, Yamamoto K, Uesugi Y, Yoshikawa S (2003) Three-dimensional CT angiography of the hepatic artery: use of multi-detector row helical CT and a contrast agent. Radiology 227:883–889PubMedCrossRef Tanikake M, Shimizu T, Narabayashi I, Matsuki M, Masuda K, Yamamoto K, Uesugi Y, Yoshikawa S (2003) Three-dimensional CT angiography of the hepatic artery: use of multi-detector row helical CT and a contrast agent. Radiology 227:883–889PubMedCrossRef
25.
go back to reference Oliver JH, Baron RL (1998) High flow injection rates versus low flow injection rates: does increasing the injection rate result in greater detection of enhancement of hepatocellular carcinoma during hepatic arterial phase CT? Radiology 209:215 Oliver JH, Baron RL (1998) High flow injection rates versus low flow injection rates: does increasing the injection rate result in greater detection of enhancement of hepatocellular carcinoma during hepatic arterial phase CT? Radiology 209:215
27.
go back to reference Wong PCY, Li Z, Guo J, Zhang A (2012) Pathophysiology of contrast-induced nephropathy. Int j cardiol 158:186–192PubMedCrossRef Wong PCY, Li Z, Guo J, Zhang A (2012) Pathophysiology of contrast-induced nephropathy. Int j cardiol 158:186–192PubMedCrossRef
28.
29.
go back to reference Rengo M, Bellini D, De Cecco CN, Osimani M, Vecchietti F, Caruso D, Maceroni MM, Lucchesi P, Iafrate F, Palombo E, Paolantonio P, Ferrari R, Laghi A (2011) The optimal contrast media policy in CT of the liver. Part II: clinical protocols. Acta Radiol 52:473–480PubMedCrossRef Rengo M, Bellini D, De Cecco CN, Osimani M, Vecchietti F, Caruso D, Maceroni MM, Lucchesi P, Iafrate F, Palombo E, Paolantonio P, Ferrari R, Laghi A (2011) The optimal contrast media policy in CT of the liver. Part II: clinical protocols. Acta Radiol 52:473–480PubMedCrossRef
30.
go back to reference Noël PB, Bendik E, Münzel D, Schneider A, Goshen L, Gringauz A, Lamash Y, Vlassenbroek A, Fingerle AA, Rummeny EJ, Dobritz M (2013) A method for improving iodine contrast enhancement in abdominal computed tomography: experimental study in a pig model. Eur Radiol 4:985–990CrossRef Noël PB, Bendik E, Münzel D, Schneider A, Goshen L, Gringauz A, Lamash Y, Vlassenbroek A, Fingerle AA, Rummeny EJ, Dobritz M (2013) A method for improving iodine contrast enhancement in abdominal computed tomography: experimental study in a pig model. Eur Radiol 4:985–990CrossRef
Metadata
Title
Evaluation of a method for improving the detection of hepatocellular carcinoma
Authors
Edgar Bendik
Peter B. Noël
Daniela Münzel
Alexander A. Fingerle
Martin Henninger
Christian Markus
Alain Vlassenbroek
Ernst J. Rummeny
Martin Dobritz
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 1/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-3006-8

Other articles of this Issue 1/2014

European Radiology 1/2014 Go to the issue